期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

准分子激光冠状动脉消蚀术治疗复杂病变的围术期配合 被引量：1

Perioperative nursing cooperation of excimer laser coronary atherectomy for the treatment of complex leisions
下载PDF
导出
摘要 目的探讨准分子激光冠状动脉消蚀术围术期护理配合的要点,制定相应的护理措施,以提高护理质量。方法通过对21例行准分子激光冠状动脉消蚀术治疗的患者围术期护理,了解其术前、术中和术后护理的要求,按其需求调整护理措施。结果经积极的围术期护理,所有患者均顺利接受手术,无1例患者出现手术并发症,达到满意的治疗效果。结论准分子激光冠状动脉消蚀术围术期护理配合临床治疗,可减少和防止并发症发生,是保证患者顺利康复的重要条件。
作者 李菲 孙宁 董玲
机构地区 沈阳军区总医院心内科
出处 《岭南心血管病杂志》 2018年第6期714-715,共2页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 准分子激光冠状动脉消蚀术 围术期 护理
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献1

二级参考文献19

  • 1Melikian N,Wijns W.Drug-eluting stents:a critique.Heart 2008; 94:145-152.
  • 2Kastrati A,Mehilli J,Pache J,Kaiser C,Valgimigli M,Kelbaek H,et al.Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.N Engl J Med 2007; 356:1030-1039.
  • 3Stone GW,Moses JW,Ellis SG,Dawkins KD,Morice MC,Colombo A,et al.Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents.N Engl J Med 2007; 356:998-1008.
  • 4Fajadet J,Wijns W,Laarman GJ,Kuck KH,Ormiston J,Münzel T,et al.Randomized,double-blind,multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions:clinical and angiographic results of the ENDEAVOR Ⅱ trial.Circulation 2006; 114:798-806.
  • 5Pfisterer M,Brunner-La Rocca H,Buser P,Rickenbacher P,Hunziker P,Mueller C,et al; for the BASKET-LATE Investigators.Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents an observational study of drug-eluting versus bare-metal stents.J Am Coll Cardiol 2006; 48:2584-2591.
  • 6Daemen J,Wenaweser P,Tsuchida K,Abrecht L,Vaina S,Morger C,et al.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:data from a large two-institutional cohort study.Lancet 2007; 369:667-678.
  • 7Eisenstein EL,Wijns W,Fajadet J,Mauri L,Edwards R,Cowper PA,et al.Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent:4-year results from the ENDEAVOR Ⅱ trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions).JACC Cardiovasc Interv 2009; 2:1178-1187.
  • 8Leon MB,Mauri L,Popma JJ,Cutlip DE,Nikolsky E,O'Shaughnessy C,et al; ENDEAVOR Ⅳ Investigators.A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR Ⅳ trial.J Am Coll Cardiol 2010; 55:543-554.
  • 9Urban P,Gershlick AH,Guagliumi G,Guyon P,Lotan C,Schofer J,et al.Safety of coronary sirolimus-eluting stents in daily clinical practice:l-year follow-up of the e-Cypher registry.Circulation 2006; 113:1434-1441.
  • 10Simonton CA,Brodie B,Cheek B,Krainin F,Metzger C,Hermiller J,et al.Comparative clinical outcomes of paclitaxel and sirolimus-eluting stents:results from a large prospective multicenter registry-STENT group.J Am Coll Cardiol 2007; 50:1214-1222.

共引文献2

同被引文献10

引证文献1

二级引证文献1

岭南心血管病杂志
2018年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部